Tim Gerarden

442 total citations
11 papers, 372 citations indexed

About

Tim Gerarden is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Tim Gerarden has authored 11 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Tim Gerarden's work include Antifungal resistance and susceptibility (5 papers), Polyamine Metabolism and Applications (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Tim Gerarden is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Polyamine Metabolism and Applications (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Tim Gerarden collaborates with scholars based in United States. Tim Gerarden's co-authors include Michael A. Pfaller, M G Rinaldi, Ken Bartizal, Robert A. Fromtling, Ana Espinel‐Ingroff, Thomas M. Kerkering, J N Galgiani, John C. M. Riley, Richard P. Wenzel and R. J. Hollis and has published in prestigious journals such as Journal of Clinical Microbiology, American Journal of Clinical Pathology and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

Tim Gerarden

11 papers receiving 357 citations

Peers

Tim Gerarden
Thomas F. Patterson United States
G Carruba Italy
Barry J. Buschelman United States
Yasemin Öz Türkiye
S. Arıkan Türkiye
João P. Frade United States
Erika J. Wolfe United States
Thomas F. Patterson United States
Tim Gerarden
Citations per year, relative to Tim Gerarden Tim Gerarden (= 1×) peers Thomas F. Patterson

Countries citing papers authored by Tim Gerarden

Since Specialization
Citations

This map shows the geographic impact of Tim Gerarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Gerarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Gerarden more than expected).

Fields of papers citing papers by Tim Gerarden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Gerarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Gerarden. The network helps show where Tim Gerarden may publish in the future.

Co-authorship network of co-authors of Tim Gerarden

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Gerarden. A scholar is included among the top collaborators of Tim Gerarden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Gerarden. Tim Gerarden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Espinel‐Ingroff, Ana, Thomas M. Kerkering, Robert A. Fromtling, et al.. (1992). Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. Journal of Clinical Microbiology. 30(12). 3138–3145. 214 indexed citations
2.
Pfaller, Michael A., et al.. (1991). Candida zeylanoides: another opportunistic yeast. Journal of Clinical Microbiology. 29(8). 1689–1692. 32 indexed citations
3.
Pfaller, Michael A., John C. M. Riley, & Tim Gerarden. (1990). Polyamine depletion and growth inhibition ofCryptococcus neoformans by α-difluoromethylornithine and cyclohexylamine. Mycopathologia. 112(1). 27–32. 18 indexed citations
4.
Pfaller, Michael A. & Tim Gerarden. (1989). Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents. Diagnostic Microbiology and Infectious Disease. 12(6). 467–471. 9 indexed citations
5.
Pfaller, Michael A., Sérgio Barsanti Wey, Tim Gerarden, A. Houston, & Richard P. Wenzel. (1989). Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents. Diagnostic Microbiology and Infectious Disease. 12(1). 1–4. 15 indexed citations
6.
Cabezudo, Ignacio, Michael A. Pfaller, Tim Gerarden, et al.. (1989). Value of the cand-tec candida antigen assay in the diagnosis and therapy of systemic candidiasis in High-Risk patients. European Journal of Clinical Microbiology & Infectious Diseases. 8(9). 770–777. 28 indexed citations
7.
Pfaller, Michael A., et al.. (1989). Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents. European Journal of Clinical Microbiology & Infectious Diseases. 8(6). 564–567. 18 indexed citations
8.
Pfaller, Michael A., et al.. (1988). Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019. Diagnostic Microbiology and Infectious Disease. 11(1). 1–9. 13 indexed citations
9.
Pfaller, Michael A., John C. M. Riley, & Tim Gerarden. (1988). Polyamine depletion and growth inhibition inCandida albicansandCandida tropicalisby α-difluoromethylornithine and cyclohexylamine. Medical Mycology. 26(2). 119–126. 13 indexed citations
10.
Pfaller, Michael A. & Tim Gerarden. (1987). The Use of the Prompt Inoculation System® in Preparing a Standardized Yeast Inoculum. American Journal of Clinical Pathology. 88(6). 743–745. 1 indexed citations
11.
Pfaller, Michael A., Tim Gerarden, & John C. M. Riley. (1987). Growth inhibition of pathogenic yeast isolates by ?-difluoromethylornithine: An inhibition of ornithine decarboxylase. Mycopathologia. 98(1). 3–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026